These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 32899957)

  • 41. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alzheimer's Disease, a Lipid Story: Involvement of Peroxisome Proliferator-Activated Receptor α.
    Sáez-Orellana F; Octave JN; Pierrot N
    Cells; 2020 May; 9(5):. PubMed ID: 32422896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects.
    Rocchi A; Orsucci D; Tognoni G; Ceravolo R; Siciliano G
    Curr Alzheimer Res; 2009 Jun; 6(3):224-37. PubMed ID: 19519304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic Syndrome and the Cellular Phase of Alzheimer's Disease.
    Pugazhenthi S
    Prog Mol Biol Transl Sci; 2017; 146():243-258. PubMed ID: 28253987
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
    Nagu P; Parashar A; Behl T; Mehta V
    J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic and central nervous system metabolic alterations in Alzheimer's disease.
    van der Velpen V; Teav T; Gallart-Ayala H; Mehl F; Konz I; Clark C; Oikonomidi A; Peyratout G; Henry H; Delorenzi M; Ivanisevic J; Popp J
    Alzheimers Res Ther; 2019 Nov; 11(1):93. PubMed ID: 31779690
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
    Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
    PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia.
    Xia D; Lianoglou S; Sandmann T; Calvert M; Suh JH; Thomsen E; Dugas J; Pizzo ME; DeVos SL; Earr TK; Lin CC; Davis S; Ha C; Leung AW; Nguyen H; Chau R; Yulyaningsih E; Lopez I; Solanoy H; Masoud ST; Liang CC; Lin K; Astarita G; Khoury N; Zuchero JY; Thorne RG; Shen K; Miller S; Palop JJ; Garceau D; Sasner M; Whitesell JD; Harris JA; Hummel S; Gnörich J; Wind K; Kunze L; Zatcepin A; Brendel M; Willem M; Haass C; Barnett D; Zimmer TS; Orr AG; Scearce-Levie K; Lewcock JW; Di Paolo G; Sanchez PE
    Mol Neurodegener; 2022 Jun; 17(1):41. PubMed ID: 35690868
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Erythrocytic Hypothesis of Brain Energy Crisis in Sporadic Alzheimer Disease: Possible Consequences and Supporting Evidence.
    Kosenko E; Tikhonova L; Alilova G; Urios A; Montoliu C
    J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31940879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota.
    Li B; He Y; Ma J; Huang P; Du J; Cao L; Wang Y; Xiao Q; Tang H; Chen S
    Alzheimers Dement; 2019 Oct; 15(10):1357-1366. PubMed ID: 31434623
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?
    Fulop T; Witkowski JM; Larbi A; Khalil A; Herbein G; Frost EH
    J Neurovirol; 2019 Oct; 25(5):634-647. PubMed ID: 30868421
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer's disease.
    Park SA; Han SM; Kim CE
    Exp Mol Med; 2020 Apr; 52(4):556-568. PubMed ID: 32284537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isotopic N,N-dimethyl leucine tags for absolute quantification of clusterin and apolipoprotein E in Alzheimer's disease.
    Liu Y; Zhang H; Zhong X; Li Z; Zetterberg H; Li L
    J Proteomics; 2022 Apr; 257():104507. PubMed ID: 35124278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How does apolipoprotein E genotype influence the relationship between physical activity and Alzheimer's disease risk? A novel integrative model.
    de Frutos Lucas J; Sewell KR; García-Colomo A; Markovic S; Erickson KI; Brown BM
    Alzheimers Res Ther; 2023 Jan; 15(1):22. PubMed ID: 36707869
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diabetes as a risk factor for Alzheimer's disease in the Middle East and its shared pathological mediators.
    Jayaraj RL; Azimullah S; Beiram R
    Saudi J Biol Sci; 2020 Feb; 27(2):736-750. PubMed ID: 32210695
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment.
    Chakrabarti S; Khemka VK; Banerjee A; Chatterjee G; Ganguly A; Biswas A
    Aging Dis; 2015 Aug; 6(4):282-99. PubMed ID: 26236550
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The oDGal Mouse: A Novel, Physiologically Relevant Rodent Model of Sporadic Alzheimer's Disease.
    Chadwick W; Maudsley S; Hull W; Havolli E; Boshoff E; Hill MDW; Goetghebeur PJD; Harrison DC; Nizami S; Bedford DC; Coope G; Real K; Thiemermann C; Maycox P; Carlton M; Cole SL
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108119
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glucose metabolism and AD: evidence for a potential diabetes type 3.
    González A; Calfío C; Churruca M; Maccioni RB
    Alzheimers Res Ther; 2022 Apr; 14(1):56. PubMed ID: 35443732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Evolution of the diagnostic frontiers of Alzheimer's disease and new therapeutic possibilities].
    Gavrilova SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11. Vyp. 2):38-44. PubMed ID: 36412155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.